Skip to main content
. 2012 Aug 9;3(8):e364. doi: 10.1038/cddis.2012.107

Figure 1.

Figure 1

Rapid NOD/SCID/huALL engraftment is associated with inferior patient outcome. Superior relapse-free survival of patients whose ALL cells engraft in NOD/SCID recipients with a TTLlong phenotype compared with TTLshort patients. Kaplan–Meier analysis, P=significance by log-rank test